Patient-specific image-based bone marrow dosimetry in Lu-177-[DOTA0,Tyr3]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach

被引：0
|
作者：
Astrid Gosewisch
Andreas Delker
Sebastian Tattenberg
Harun Ilhan
Andrei Todica
Julia Brosch
Lena Vomacka
Anika Brunegraf
Franz Josef Gildehaus
Sibylle Ziegler
Peter Bartenstein
Guido Böning
机构：
[1] LMU Munich,Department of Nuclear Medicine, University Hospital
来源：
EJNMMI Research | / 8卷
关键词：
Radionuclide therapy; Bone marrow; Dosimetry; Hybrid imaging; Lutetium-177; Prostate cancer; PSMA; mCRPC; Neuroendocrine tumour; Octreotate; NET;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 30 条
  • [11] 177Lu-[DOTA0,Tyr3] Octreotate Therapy in Patients With Disseminated Neuroendocrine Tumors: Analysis of Dosimetry With Impact on Future Therapeutic Strategy
    Garkavij, Michael
    Nickel, Mattias
    Sjogreen-Gleisner, Katarina
    Ljungberg, Michael
    Ohlsson, Tomas
    Wingardh, Karin
    Strand, Sven-Erik
    Tennvall, Jan
    CANCER, 2010, 116 (04) : 1084 - 1092
  • [12] 177Lu-[DOTA0,Tyr3] octreotate therapy in iodine refractory thyroid cancer: Comparison of dosimetry with therapy of thyroid cancer and neuroendocrine tumors
    Yeyin, N.
    Demirci, E.
    Toklu, T.
    Kabasakal, L.
    Aygun, A.
    Ocak, M.
    Selcuk, N.
    Kanmaz, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S306 - S306
  • [13] Influence of patient motion on image-based dosimetry for 177Lu-PSMA therapy
    Resch, S.
    Rumiantcev, M.
    Liubchenko, G.
    Brendel, M.
    Ziegler, S. I.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S211 - S211
  • [14] Automatic image-based segmentation and partial volume correction for Lu-177-PSMA-617 bone marrow dosimetry
    Lu, Zhonglin
    Liu, Yibin
    Chen, Gefei
    Jiang, Han
    Afshar-Oromieh, Ali
    Rominger, Axel
    Shi, Kuangyu
    Mok, Greta
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [15] Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
    Elahe Mahmoudi
    Elahe Pirayesh
    Mohammad Reza Deevband
    Mahasti Amoui
    Mehrdad Ghorbani Rad
    Mahdi Ghorbani
    Nuclear Medicine and Molecular Imaging, 2021, 55 : 237 - 244
  • [16] Patient-Specific Dosimetry in Radioligand Therapy (RLT) for Metastatic Prostate Cancer Using 177Lu-DKFZ-PSMA-617
    Mahmoudi, Elahe
    Pirayesh, Elahe
    Deevband, Mohammad Reza
    Amoui, Mahasti
    Rad, Mehrdad Ghorbani
    Ghorbani, Mahdi
    NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 55 (05) : 237 - 244
  • [17] Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy
    Brosch-Lenz, Julia
    Delker, Astrid
    Voelter, Friederike
    Unterrainer, Lena M.
    Kaiser, Lena
    Bartenstein, Peter
    Ziegler, Sibylle
    Rahmim, Arman
    Uribe, Carlos
    Boening, Guido
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (05) : 767 - 774
  • [18] The role of kidneys and bone marrow as critical organs during Lu-177-PSMA-DKFZ-617 therapy depending on the patient-specific tumor load
    Gosewisch, Astrid
    Ilhan, Harun
    Todica, Andrei
    Brosch, Julia
    Kaiser, Lena
    Bartenstein, Peter
    Boening, Guido
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [19] Validation of a simplified single time point image-based dosimetry approach for 177Lu-PSMA therapy
    Brosch-Lenz, J.
    Gosewisch, A.
    Voelter, F.
    Kaiser, L.
    Bartenstein, P.
    Ziegler, S.
    Rahmim, A.
    Uribe, C.
    Boening, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S73 - S74
  • [20] Improvement of PFS and OS after salvage therapy with 177-Lu[Dota0, Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumours - the Rotterdam cohort
    van der Zwan, W. A.
    Brabander, T.
    Kam, B. L. K.
    Teunissen, J. J. M.
    Krenning, E. P.
    Kwekkeboom, D. J. K.
    de Herder, W. W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S156 - S157
123